Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Harvoni and Ribavirin in HCV with advanced liver disease or post-transplant
NCT02010255Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Jan 2014
- Primary completion
- May 2015
- Countries
- 12
01
Overview
A Phase 2 trial of ledipasvir in hepatitis C virus infection, sponsored by Gilead Sciences. Started Jan 2014; status: completed.
02
Drugs
ledipasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT02010255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02010255.